Furuse, Junji http://orcid.org/0000-0003-0663-6117
Izumi, Namiki
Motomura, Kenta
Inaba, Yoshitaka
Katamura, Yoshio
Kondo, Yasuteru
Yabushita, Kazuhisa
Motoyoshi, Katsuaki
Kudo, Masatoshi
Funding for this research was provided by:
Eisai Co., Ltd.
Article History
Accepted: 5 December 2022
First Online: 5 January 2023
Declarations
:
: This work was supported by Eisai Co., Ltd. (Tokyo, Japan).
: J. Furuse received honoraria from Ono Pharmaceutical, Bayer, Eisai, Eli Lilly Japan, MSD, Yakult Honsha, Chugai Pharma, Novartis Pharma, AstraZeneca, Pfizer, Takeda, Taiho Pharmaceutical, Sanofi, Mylan EPD, EA Pharma, Kyowa Hakko Kirin, Daiichi Sankyo, Teijin Pharma, Servier Japan, and Incyte Biosciences Japan; and research grants from Ono Pharmaceutical, MSD, Merck Bio, J-Pharma, Taiho Pharmaceutical, Takeda, Chugai Pharma, AstraZeneca, Yakult Honsha, Eisai, Daiichi Sankyo, Mochida, Sanofi, Sumitomo Dainippon, Bayer, Astellas, and Incyte Biosciences Japan. N. Izumi received honoraria from Eisai, Chugai Pharmaceutical, Takeda Pharmaceutical, Eli Lilly, and Bayer. K. Motoyoshi is an employee of Eisai Co., Ltd. M. Kudo received honoraria from Eisai, Bayer, MSD, EA Pharma, Eli Lilly, Chugai Pharmaceutical, and Ono Pharmaceutical; and research grants from Eisai, Takeda Pharmaceutical, Otsuka Pharmaceutical, Taiho Pharmaceutical, EA Pharma, Gilead Sciences, AbbVie, Sumitomo Dainippon Pharma, Chugai Pharmaceutical, and Ono Pharmaceutical. K. Motomura, Y. Inaba, Y. Katamura, Y. Kondo, and K. Yabushita declare that they have no conflict of interest.
: J. Furuse and K. Motoyoshi contributed to the conception and design of this study. All authors contributed to data interpretation. K. Motoyoshi contributed to the manuscript drafting. All the authors critically reviewed the manuscript for important intellectual content and approved the final version for publication.
: This study was conducted as part of pharmacovigilance activities as required by the Japanese Pharmaceutical and Medical Devices Agency. Therefore, no ethical approval was required. The study was performed in accordance with the provisions of the Declaration of Helsinki, Pharmaceutical Affairs Law, and Ministerial Ordinance on Good Post-Marketing Study Practice in Japan.
: Informed consent was obtained from all participants included in the study.
: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.